EFI-001 Research Kit from Effigene Pharmaceuticals

EFI-001 Research Kit

EFI-001 Research Kit

Effigene Pharmaceuticals

Reagent Significantly Boosts RNAi Effects
Effigene’s EFI-001 Research Kit contains a proprietary formulation for enhancing RNAi silencing effects to 80~90% for both siRNA and shRNA in common eukaryotic cell lines, and significantly lowers more than 5 folds of the dose that is needed to achieve desirable knock down ratio. EFI-001 also significantly prolongs silencing duration and provides more choices for users to select desirable sequences shown to have minimal or no off-target effects.

EFI-001 Research Kit

Article Tools
  • Email a Colleague
  • Print
  • Comments
  • ShareThis
advertisement

You do not have JavaScript enabled or are using an older version of Adobe Flash. You can update your version of Adobe Flash here.

Email Newsletter Sign-Up

Stay updated on the latest technologies and news with Biocompare's newsletters
(See samples here)






Select All

Loading

Loading